Alzheimer's/DementiaCMSFDAMedicare - GeneralPart D/Prescription Drugs

26 state attorneys general urge Medicare to cover Alzheimer’s treatments

(By Rylee Wilson for Becker’s Hospital Review)

Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for Alzheimer’s disease.

In a letter sent to HHS Secretary Xavier Becerra and CMS Administrator Chiquita Brooks-LaSure, the bipartisan group of attorneys general urged the agencies to “ensure all patients have access to FDA-approved treatments.” Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org

Leave a Reply